HALIX is a Healthcare CDMO specializing in biopharmaceuticals, including recombinant proteins and antibodies, viral vectors and vaccines. With state-of-the-art GMP manufacturing facilities in Leiden Bio Science Park, we support pharmaceutical companies worldwide with the development & commercialization of biologics enabling the treatment & prevention of life threatening conditions such as cancer, COVID-19, influenza and other infectious diseases. At HALIX, we are committed to delivering cutting-edge solutions, fostering meaningful partnerships, and upholding our promise to drive impact in the biotech and healthcare industries with quality, compliance, and sustainability at the heart of every process.
2012